Inventor · disambiguated record
Ryan J. Watts
Also filed as: WATTS RYAN · WATTS RYAN J · WATTS RYAN JEFFERSON
40 granted patents·33 pending applications·415 citations·filing 2003–2024
98Inventor score
Top patents by PatentIndex Score
73 records- 0197US9708406B2Anti-transferrin receptor antibodies and methods of useGENENTECH INC·Filed 2014·Granted Jul 18, 2017·87 cites·51 claims
- 0297US7892544B2Humanized anti-beta-amyloid antibodyAC IMMUNE SA·Filed 2007·Granted Feb 22, 2011·55 cites·26 claims
- 0396US11912778B2Methods of engineering transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2022·Granted Feb 27, 2024·2 cites·17 claims
- 0494US9611323B2Low affinity blood brain barrier receptor antibodies and uses thereforGENENTECH INC·Filed 2014·Granted Apr 4, 2017·40 cites·17 claims
- 0594US9585956B2Polynucleotides encoding anti-amyloid beta monoclonal antibodiesAC IMMUNE SA·Filed 2015·Granted Mar 7, 2017·8 cites·21 claims
- 0694US8246954B2Methods of treating amyloidosis with humanized anti-beta-amyloid antibodiesPFEIFER ANDREA·Filed 2009·Granted Aug 21, 2012·24 cites·57 claims
- 0794US7994286B2Neuropilin antagonistsGENENTECH INC·Filed 2008·Granted Aug 9, 2011·17 cites·11 claims
- 0893US12162948B2Methods of engineering transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2024·Granted Dec 10, 2024·1 cites·16 claims
- 0993US9175094B2Monoclonal antibodyAC IMMUNE SA·Filed 2013·Granted Nov 3, 2015·9 cites·36 claims
- 1093US8124353B2Methods of treating and monitoring disease with antibodiesPFEIFER ANDREA·Filed 2007·Granted Feb 28, 2012·20 cites·11 claims
- 1192US10808036B2Anti-transferrin receptor antibodies and methods of useGENENTECH INC·Filed 2017·Granted Oct 20, 2020·5 cites·48 claims
- 1292US8796439B2Nucleic acid molecules encoding a humanized antibodyPFEIFER ANDREA·Filed 2012·Granted Aug 5, 2014·15 cites·47 claims
- 1391US7834154B2Anti-ROBO4 antibodies and uses thereforGENENTECH INC·Filed 2008·Granted Nov 16, 2010·23 cites·12 claims
- 1490US10941215B2Low affinity blood brain barrier receptor antibodies and uses thereofGENENTECH INC·Filed 2018·Granted Mar 9, 2021·6 cites·16 claims
- 1590US8048420B2Monoclonal antibodyAC IMMUNE SA·Filed 2008·Granted Nov 1, 2011·12 cites·36 claims
- 1689US8378080B2Neuropilin antagonistsGENENTECH INC·Filed 2012·Granted Feb 19, 2013·9 cites·9 claims
- 1788US11795232B2Engineered transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2019·Granted Oct 24, 2023·2 cites·38 claims
- 1888US10508151B2Anti-transferrin receptor antibodies and methods of useGENENTECH INC·Filed 2015·Granted Dec 17, 2019·7 cites·40 claims
- 1988US9453079B2Methods and compositions for neural disease immunotherapyGENENTECH INC·Filed 2014·Granted Sep 27, 2016·9 cites·35 claims
- 2088US2024141058A1Methods of engineering transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2187US11124562B2Anti-ApoE antibodiesUNIV WASHINGTON·Filed 2017·Granted Sep 21, 2021·3 cites·15 claims
- 2287US2024018253A1Engineered transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 2386US8920805B2Inhibition of tumor metastasis by anti-neuropilin 2 antibodiesGENENTECH INC·Filed 2013·Granted Dec 30, 2014·7 cites·38 claims
- 2485US9101645B2Modulation of axon degenerationWATTS RYAN·Filed 2009·Granted Aug 11, 2015·20 cites·9 claims
- 2585US8613923B2Monoclonal antibodyPFEIFER ANDREA·Filed 2008·Granted Dec 24, 2013·7 cites·12 claims
- 2685US2025297023A1Methods of engineering transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 2784US9403902B2Methods of treating ocular disease associated with amyloid-beta-related pathology using an anti-amyloid-beta antibodyPFEIFER ANDREA·Filed 2008·Granted Aug 2, 2016·7 cites·9 claims
- 2884US8648173B2Inhibition of tumor metastasis by anti neuropilin 2 antibodiesWU YAN·Filed 2007·Granted Feb 11, 2014·7 cites·20 claims
- 2984US2025145697A1Anti-apoe antibodiesWASHINGTON UNIVERSITY ST LOUIS·Filed 2024·Application pending·0 cites
- 3083US11008403B2Anti-transferrin receptor / anti-BACE1 multispecific antibodies and methods of useGENENTECH INC·Filed 2015·Granted May 18, 2021·3 cites·25 claims
- 3182US8795660B2Neuropilin antagonistsGENENTECH INC·Filed 2013·Granted Aug 5, 2014·2 cites·18 claims
- 3282US2024024432A1Engineered transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 3382US2024271326A1Methods of engineering transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 3476US11926660B2Anti-ApoE antibodiesWASHINGTON UNIVERSITY ST LOUIS·Filed 2021·Granted Mar 12, 2024·0 cites·8 claims
- 3576US9221900B2Methods for identifying safe and functional humanized antibodiesPFEIFER ANDREA·Filed 2011·Granted Dec 29, 2015·3 cites·26 claims
- 3672US8211429B2Neuropilin antagonistsWATTS RYAN J·Filed 2011·Granted Jul 3, 2012·2 cites·18 claims
- 3770US2021292440A1Low Affinity Blood Brain Barrier Receptor Antibodies and Uses ThereofGENENTECH INC·Filed 2021·Application pending·0 cites
- 3867US11746160B2Antibodies against BACE1 and use thereof for neural disease immunotherapyGENENTECH INC·Filed 2020·Granted Sep 5, 2023·0 cites·6 claims
- 3967US7012063B2Reducing axon degeneration with proteasome inhibitorsCHILDRENS MEDICAL CENTER·Filed 2003·Granted Mar 14, 2006·2 cites·19 claims
- 4067US2021317197A1Humanized antibodyAC IMMUNE SA·Filed 2020·Application pending·0 cites
- 4167US2020369746A1Engineered transferrin receptor binding polypeptidesDENALI THERAPEUTICS INC·Filed 2020·Application pending·0 cites
- 4266US11098129B2Anti-transferrin receptor antibodies and methods of useGENENTECH INC·Filed 2019·Granted Aug 24, 2021·0 cites·34 claims
- 4365US2021087288A1Anti-transferrin receptor antibodies and methods of useGENENTECH INC·Filed 2020·Application pending·0 cites
- 4465US2022227847A1Humanized antibodyAC IMMUNE SA·Filed 2021·Application pending·0 cites
- 4564US8772457B2BACE1 antibodiesATWAL JASVINDER·Filed 2011·Granted Jul 8, 2014·1 cites·28 claims
- 4664US2020055928A1Humanized antibodyAC IMMUNE SA·Filed 2019·Application pending·0 cites
- 4762US2010221262A1Anti-unc5b antibodies and methods of useGENENTECH INC·Filed 2009·Application pending·0 cites
- 4862US2009155249A1Humanized antibody igg1GENENTECH INC·Filed 2008·Application pending·0 cites
- 4960US7238659B2Reducing axon degeneration with proteasome inhibitorsUNIV LELAND STANFORD JUNIOR·Filed 2005·Granted Jul 3, 2007·0 cites·20 claims
- 5059US2016304613A1Neuropilin antagonistsGENENTECH INC·Filed 2015·Application pending·0 cites
Showing the top 50 of 73 patent records by PatentIndex Score.
Join the waitlist — get patent alerts
Get an alert when Ryan J. Watts files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →